ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 39664414

Strategies for intravesical drug delivery: From bladder physiological barriers and potential transport mechanisms.

Li ZA and 5 others. Acta Pharm Sin B, 2024. Cited by 23 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Strategies for intravesical drug delivery: From bladder physiological barriers and potential transport mechanisms. Papers, record 39664414. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39664414

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Strategies for intravesical drug delivery: From bladder physiological barriers and potential transport mechanisms.
PubMed
Journal
Acta Pharm Sin B
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
4.13, provisional
iCite
Revised in PubMed
2024-12-13
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Li ZAZheng-An
2Wen KCKai-Chao
3Liu JHJi-Heng
4Zhang CChuan
5Zhang FFeng
6Li FQFeng-Qian

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References113

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124,366,662Biomimetic delivery strategies at the urothelium: targeted cytoinvasion in bladder cancer cells via lectin bioconjugates.Pharm Res2014https://conductscience.org/library/papers/24366662PubMed
233,617,902Target specific tight junction modulators.Adv Drug Deliv Rev2021https://conductscience.org/library/papers/33617902PubMed
330,608,136Tunneling Nanotubular Expressways for Ultrafast and Accurate M1 Macrophage Delivery of Anticancer Drugs to Metastatic Ovarian Carcinoma.ACS Nano2019https://conductscience.org/library/papers/30608136PubMed
423,261,216In vivo disassembly of IV administered siRNA matrix nanoparticles at the renal filtration barrier.Biomaterials2013https://conductscience.org/library/papers/23261216PubMed
531,443,960European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.Eur Urol2019https://conductscience.org/library/papers/31443960PubMed
622,889,683Lectin bioconjugates trigger urothelial cytoinvasion--a glycotargeted approach for improved intravesical drug delivery.Eur J Pharm Biopharm2012https://conductscience.org/library/papers/22889683PubMed
710,699,266Lectin-mediated drug delivery: the second generation of bioadhesives.J Control Release2000https://conductscience.org/library/papers/10699266PubMed
837,038,914Floating poly(lactic-co-glycolic acid)-based controlled-release drug delivery system for intravesical instillation.J Int Med Res2023https://conductscience.org/library/papers/37038914PubMed
915,523,091Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.J Natl Cancer Inst2004https://conductscience.org/library/papers/15523091PubMed
1029,079,537Enzyme decorated drug carriers: Targeted swords to cleave and overcome the mucus barrier.Adv Drug Deliv Rev2018https://conductscience.org/library/papers/29079537PubMed

1 to 10 of 113

See all 113 references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42,941,789pH-Responsive Erdafitinib Liposomes with FGFR3 Targeting for Intravesical Bladder Cancer Therapy.Int J Mol Sci2026https://conductscience.org/library/papers/42941789PubMed
42,940,072Therapeutic Migration in Interstitial Cystitis/Bladder Pain Syndrome: Cross-Organ Lessons for Urothelial Healing and Endotype-Guided Therapy.Biomedicines2026https://conductscience.org/library/papers/42940072PubMed
42,898,651Localized nanomedicine for urologic cancers: anatomy-guided design and clinical translation.Mater Today Bio2026https://conductscience.org/library/papers/42898651PubMed
42,882,896Metabolic Reprogramming in Bladder Cancer: Molecular Drivers, Immune Regulation and Therapeutic Opportunities.Cancers (Basel)2026https://conductscience.org/library/papers/42882896PubMed
42,824,364Nanoparticle-based therapeutic platforms for inflammatory disorders of the urinary system: Engineering local delivery, biointerface regulation, and smart responsive therapy.Mater Today Bio2026https://conductscience.org/library/papers/42824364PubMed
42,769,902Nanorobots and Exosomes: Driving the New Frontier for Bladder Tumors through Non-Coding RNAs.Oncol Res2026https://conductscience.org/library/papers/42769902PubMed
42,644,909Catheter-Deliverable Floating Hydrogels for Sustained Intravesical Drug Release.Gels2026https://conductscience.org/library/papers/42644909PubMed
42,605,362Advances in NIR-II Fluorescence Laparoscopy for Precision Diagnosis and Theranostics of Urological Oncology.Int J Nanomedicine2026https://conductscience.org/library/papers/42605362PubMed
42,328,282Bladder-Preserving Platforms for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer.Onco Targets Ther2026https://conductscience.org/library/papers/42328282PubMed
42,189,325Functional hydrogel biomaterials for urological diagnosis and treatment-design strategies and application progress: a review.J Mater Sci Mater Med2026https://conductscience.org/library/papers/42189325PubMed

1 to 10 of 19

See all 19 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39664414

GET https://conductscience.org/api/papers/v1/39664414/references?page=2

API referenceFor AI assistants